Akston Biosciences Corp
BEVERLY, MA · CIK 0001776612 · Biotech · Private
Protein therapeutics for veterinary medicine
akstonbio.com →- Grants
- $4.1M
- 5 awards
- Sector median: 1
- Raised
- $17M
- 5 Form D · Apr 2022
- 54 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 25 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Selective Removal of Insulin-Specific B-cells to Prevent Type I Diabetes in NOD Mice | $249,821 | |
| Federal grant | Department of Health and Human Services · Phase II · Selective Depletion of Insulin-Specific B cells to Prevent Type 1 Diabetes | $998,123 | |
| Federal grant | Department of Health and Human Services · Phase II · Selective Depletion of Insulin-Specific B cells to Prevent Type 1 Diabetes | $998,998 | |
| Private capital raised | Form D · SEC | $2,532,500 | |
| Federal grant | Department of Health and Human Services · Phase II · IND-enabling assay validation and toxicology studies on AKS-107: a novel antigen-specific B cell therapeutic to prevent Type 1 Diabetes | $978,643 | |
| Private capital raised | Form D · SEC | $5,101,514 | |
| Federal grant | Department of Health and Human Services · Phase II · IND-enabling assay validation and toxicology studies on AKS-107: a novel antigen-specific B cell therapeutic to prevent Type 1 Diabetes | $923,642 | |
| Private capital raised | Form D · SEC | $3,388,591 | |
| Private capital raised | Form D · SEC | $1,000,029 | |
| Private capital raised | Form D · SEC | $5,162,723 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3370 | SPERAGEN, INC. | — | — |
| 3371 | SERVA ENERGY, INC. | — | $7.1M |
| 3372 | SwanBio Therapeutics | — | — |
| 3373 | Akston Biosciences Corp | — | $17M |
| 3374 | Aqualung Therapeutics Corp. | — | $3.1M |
| 3375 | Concerto Biosciences, Inc. | — | $16M |
| 3376 | UNCO THERAPEUTICS LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Lovick CannonDirector
- Robyn DavisDirector
- James HerrimanExecutive Officer
- Thomas LancasterDirector · Executive Officer
- Todd ZionDirector · Executive Officer
Patents
- Insulin-fc Fusion Proteins And Methods Of Use To Treat Cancergranted
- PD-L1 Analog Fusion Proteins For Antigen Specific Immunotherapy And Methods Of Usegranted
- Fc Fusion Protein Therapeutics For Companion Animal Obesity And Methods Of Useapplication
- Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Usegranted
- PD-L1 Analog Fusion Proteins For Antigen Specific Immunotherapy And Methods Of Useapplication
- PD-L1 Analog Fusion Proteins For Antigen Specific Immunotherapy And Methods Of Usegranted
- Ultra-long Acting Insulin-fc Fusion Proteingranted
- Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Usegranted
- Ultra-long Acting Insulin-fc Fusion Protein And Methods Of Usegranted
- Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Usegranted
- Antigen Specific Immunotherapy For COVID-19 Fusion Proteins And Methods Of Usegranted
- Ultra-long Acting Insulin-fc Fusion Proteins And Methods Of Usegranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.